October 2, 2018
Flex Announces Release Date for Second Quarter Fiscal 2019 Earnings
Flex (NASDAQ: FLEX) will hold a conference call to discuss its second quarter fiscal 2019 results on Thursday, October 25, 2018 at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). The dial-in number for the conference call is 877-201-0168 with passcode Q2Flex. The live webcast of the call and accompanying slides can be accessed on the Flex Investor Relations website at https://investors.flex.com. An audio replay and transcript will also be available after the call. About Flex Flex is the Sketch-to-Scale ® solutions provider that designs and builds Intelligent Products for a Connected World ® . With approximately 200,000 professionals across 30 countries, Flex provides innovative design, engineering, manufacturing, real-time supply chain insight and logistics services to companies of all sizes in various industries and end-markets. For more information, visit flex.com or follow us on Twitter @flexintl. Flex – Live Smarter ® Investors & Analysts Kevin Kessel 1 (408)...
Read More
September 12, 2018
Flex Announces BrightInsight Clinical Board to Advance Development of Digital Solutions for Pharma and Medtech
Flex (NASDAQ:FLEX), the Sketch-to-Scale® solutions provider that designs and builds Intelligent Products for a Connected World ®, has assembled a clinical advisory board to leverage the perspectives of leading doctors for the development of powerful digital health solutions that integrate into and improve clinical workflow to make a real-world impact on patient outcomes. Going beyond consumer-grade digital health, Flex's Digital Health business and the BrightInsight™ Clinical Board will be focused on advancing medical-grade digital health solutions that effectively integrate into providers' clinical workflow with the goal of improving patient outcomes. "As we continue to develop leading-edge digital health solutions, it's paramount that we keep clinical workflow and the clinician's point-of-view top of mind," said Kal Patel, M.D. and SVP of Digital Health at Flex. "Although we are seeing a proliferation of effective digital health solutions coming to market, they almost universally...
Read More
August 21, 2018
Flex Receives Approval And Authorization For Share Repurchases
Flex (NASDAQ: FLEX) today announced that it received shareholder approval to purchase up to 20% of its outstanding shares during its Annual General Meeting held on August 16, 2018. Since the beginning of the Company's share repurchase program commencing in the first quarter of fiscal 2011, through the first quarter of fiscal 2019 ended June 29, 2018, the Company has repurchased approximately 370.6 million shares for approximately $3.1 billion and retired all of these shares. Under the Company's currently approved share repurchase program, the Board of Directors authorized repurchases of its outstanding ordinary shares for up to $500 million in accordance with the share repurchase mandate approved by the Company's shareholders. Share repurchases, if any, will be made in the open market and in compliance with SEC Rule 10b-18. The timing and actual number of shares repurchased will depend on a variety of factors including price, market conditions and applicable legal requirements. The...
Read More